Background: Economic evaluations of interventions for postnatal depression (PND) are essential to ensure optimal healthcare decision-making. Due to the wide-ranging effects of PND on the mother, baby and whole family, there is a need to include outcomes for all those affected and to include health and non-health outcomes for accurate estimates of cost-effectiveness. This study aimed to identify interventions to prevent or treat PND for which an economic evaluation had been conducted and to evaluate the health and non-health outcomes included.
Methods: A systematic review was conducted applying a comprehensive search strategy across eight electronic databases and other sources. Full or partial economic evaluations of interventions involving preventive strategies (including screening), and any treatments for women with or at-risk of PND, conducted in OECD countries were included. We excluded epidemiological studies and those focussing on costs only. The included studies underwent a quality appraisal to inform the analysis.
Results: Seventeen economic evaluations met the inclusion criteria, the majority focused on psychological /psychosocial interventions. The interventions ranged from additional support from health professionals, peer support, to combined screening and treatment strategies. Maternal health outcomes were measured in all studies; however child health outcomes were included in only four of them. Across studies, the maternal health outcomes included were quality-adjusted-life-years gained, improvement in depressive symptoms, PND cases detected or recovered, whereas the child health outcomes included were cognitive functioning, depression, sleep and temperament. Non-health outcomes such as couples' relationships and parent-infant interaction were rarely included. Other methodological issues such as limitations in the time horizon and perspective(s) adopted were identified, that were likely to result in imprecise estimates of benefits.
Conclusions: The exclusion of relevant health and non-health outcomes may mean that only a partial assessment of cost-effectiveness is undertaken, leading to sub-optimal resource allocation decisions. Future research should seek ways to expand the evaluative space of economic evaluations and explore approaches to integrate health and non-health outcomes for all individuals affected by this condition. There is a need to ensure that the time horizon adopted in studies is appropriate to allow true estimation of the long-term benefits and costs of PND interventions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963067 | PMC |
http://dx.doi.org/10.1186/s12884-018-1738-9 | DOI Listing |
J Med Internet Res
January 2025
Department of Health Promotion and Health Education, College of Education, National Taiwan Normal University, Taipei, Taiwan.
Background: Chronic kidney disease (CKD) imposes a significant global health and economic burden, impacting millions globally. Despite its high prevalence, public awareness and understanding of CKD remain limited, leading to delayed diagnosis and suboptimal management. Traditional patient education methods, such as 1-on-1 verbal instruction or printed brochures, are often insufficient, especially considering the shortage of nursing staff.
View Article and Find Full Text PDFJ Trauma Acute Care Surg
January 2025
From the Department of Surgery (E.M., L.G., J.S.), Emory University School of Medicine, Atlanta, Georgia; Georgia Trauma Commission (E.A., G.S.), Madison; Wellstar Medical College of Georgia, (R.M.) Medical College of Georgia Augusta University, Augusta; Grady Health System (S.T.), Atlanta; Memorial Health University Medical Center (J.D.), Savannah; Department of Surgery (D.A.), Atrium Health Navicent, Macon, Georgia.
Background: American College of Surgeons (ACS) trauma center verification has demonstrated improved outcomes at individual centers, but its impact on statewide Trauma Quality Improvement Program (TQIP) Collaboratives is unknown. A statewide TQIP Collaborative, founded in 2011, noted underperformance in six of eight patient cohorts identified in the TQIP Collaborative report. We hypothesized that requiring ACS verification for level I and II trauma centers would result in improved outcomes for the state collaborative.
View Article and Find Full Text PDFEur Radiol
January 2025
Radboud University Medical Center, IQ Health science department, Nijmegen, The Netherlands.
Objectives: It is uncertain what the effects of introducing digital breast tomosynthesis (DBT) in the Dutch breast cancer screening programme would be on detection, recall, and interval cancers (ICs), while reading times are expected to increase. Therefore, an investigation into the efficiency and cost-effectiveness of DBT screening while optimising reading is required.
Materials And Methods: The Screening Tomosynthesis trial with advanced REAding Methods (STREAM) aims to include 17,275 women (age 50-72 years) eligible for breast cancer screening in the Netherlands for two biennial DBT screening rounds to determine the short-, medium-, and long-term effects and acceptability of DBT screening and identify an optimised strategy for reading DBT.
Alzheimers Dement
December 2024
University of Southern California, Los Angeles, CA, USA.
Background: The value payers and policymakers traditionally place on novel treatments for Alzheimer's and other neurological diseases that cause cognitive impairment (CI) and dementia often ignores disease baseline severity. More patient-centered economic evaluations-such as those estimating "insurance value"-incorporate the fact that individuals are typically risk-averse and place high value on generous coverage of treatments in the event that they develop CI, such as severe dementia, later in life. This study aims to estimate this insurance value, accounting for risk aversion, relative to the value of the same treatment based on traditional payer cost effectiveness approaches.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
National Center for Geriatrics and Gerontology, Obu, Aichi, Japan.
Background: This post-hoc subgroup analysis aimed to estimate the potential cost-effectiveness of a Japanese multimodal intervention trial for the prevention of dementia (J-MINT) from a societal perspective.
Method: Using a Markov model, we estimated the economic impact of J-MINT on disease prevention, drawing on data from the 2019 J-MINT trial and relevant published literature. The trial, a randomized controlled trial (RCT), focused on participants aged 65 to 85 years with mild cognitive impairment.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!